Odyssey Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ODTX | ACRS | CRVS | OBX | ANNX | OMER | |
|---|---|---|---|---|---|---|
| Market cap | 937.14M | 570.34M | 889.16M | 678.88M | 820.88M | 1.32B |
| P/E (TTM) | — | — | — | — | — | 14.9 |
| Forward P/E | -4.5 | -5.1 | -9.9 | -5.2 | -4.0 | 14.8 |
| Price/book | 2.5 | 4.1 | 3.9 | -0.8 | 4.1 | -25.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +18.76% | +62.11% | +35.17% | −37.20% | +43.38% | +176.29% |
| Today | −9.60% | −1.60% | +7.53% | −16.93% | +3.34% | −0.49% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ODTX news ›Odyssey Therapeutics, Inc. (NASDAQ:ODTX) Stock Rated “Moderate Buy” by Sell-Side Analysts
Posted by Sarita Garza on Nov 4th, 2026 Get Our Latest Report on Odyssey Therapeutics ODTX stock opened at $21.57 on Friday. The firm has a fifty day simple moving average of $21.58. Odyssey Therapeutics has a fifty-two week low of $15.10…
Transcript : Odyssey Therapeutics, Inc. - Special Call
Presentation Operator MessageOperator Good day, and welcome to the Odyssey Therapeutics UEG Week 2026 Investor webcast. [Operator Instructions] Please note, this call is being recorded. I'll pass Transcript : Odyssey Therapeutics, Inc. -…
30,445,121 Common Stock of Odyssey Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 4-NOV-2026.
These Common Stock will be under lockup for 181 days starting from 7-MAY-2026 to... 30,445,121 Common Stock of Odyssey Therapeutics, Inc are subject to a Lock-Up Agreement Ending on 4-NOV-
Odyssey Therapeutics, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Odyssey Therapeutics, Inc. with the company of your choice via a Relative Strength chart. Real-time ODTX price, Nasdaq stock exchange Relative Strength Chart Odyssey Therapeutics, Inc. Biotechnology & Medical Research All financial…
Odyssey Therapeutics, Inc.’s Lock-Up Period Set To End Tomorrow (NASDAQ:ODTX)
Posted by Kim Johansen on Nov 3rd, 2026 Check Out Our Latest Report on Odyssey Therapeutics ODTX opened at $19.53 on Tuesday. The company has a 50-day moving average of $21.66. Odyssey Therapeutics has a 1 year low of $15.10 and a 1 year…
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
Company to host conference call and webcast following the presentation on Tuesday, October 20, at 8:00 a.m. EDTBOSTON, Oct. 06, 2026 (GLOBE NEWS... Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for…
Odyssey Therapeutics initiated with a Buy at UBS
UBS initiated coverage of Odyssey Therapeutics (ODTX) with a Buy rating and $27 price target The firm views the company’s OD-001, a novel oral ... Odyssey Therapeutics initiated with a Buy at UBS UBS initiated coverage of Odyssey…
Analysts Conflicted on These Healthcare Names: Insight Molecular Diagnostics (IMDX), Tandem Diabetes Care (TNDM) and Odyssey Therapeutics, Inc. (ODTX)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Insight Molecular Diagnostics (IMDX), Tandem Diabetes Care (TNDM) and Odyssey Therapeutics, Inc. (ODTX). In a report released yesterday, Mark Massaro from…
Obsidian Therapeutics (NASDAQ:OBX) Upgraded at Wall Street Zen
Posted by Sarita Garza on Oct 28th, 2026 Wall Street Zen upgraded shares of Obsidian Therapeutics (NASDAQ:OBX – Free Report) from a sell rating to a hold rating in a research report released on Sunday morning,Wall Street Zen reports. View…
Odyssey Therapeutics Highlights OD-001 Phase IIa UC Data, Sets 2027 Trial Readouts
Posted by Defense World Staff on Oct 27th, 2026 At 20 mg twice daily, Odyssey reported clinical remission of 27%, symptomatic remission of nearly 50%, and clinical response of more than 60% at week 12. The company said symptomatic…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com11
- markets.businessinsider.com6
- themarketsdaily.com4
- globenewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.